Difference between revisions of "Advanced Tissue Sciences"
m (Wikify foreskin and circumcision.)
(Insert SEEALSO section.)
|Line 77:||Line 77:|
Latest revision as of 03:08, 10 February 2020
Advanced Tissue Sciences is a corporation based in La Jolla, CA. They are the makers of Dermagraft-TC, which is an artifical skin created from harvested foreskins from infant circumcision. They are also the makers of NouriCel, another product made from harvested foreskins, and one of the main ingredients of SkinMedica's TNS Recovery Complex product.
Advanced Tissue Sciences has sold about $1 million worth of cultured dermis to Proctor & Gamble, Helene Curtis, and other such businesses for pre-market testing. Advanced Tissue Science's foreskin-derived merchandise held a $32 million stock offering in the beginning of 1992.
In 1996 alone, Advanced Tissue Sciences could boast of a healthy $663.9 million market capitalization performance.
Dermagraft-TC: Overview, Advanced Biohealing, Inc.. Retrieved 6 March 2011.
Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
The Foreskin Mafia, Acroposthion.com. Retrieved 6 March 2011.
TNS contains... NouriCel-MD which is... a combination of Natural Growth Factors, matrix proteins, and soluble collagen. Human Growth Factors extracted from cultured cells of foreskin...
- (12 February 2002).
SkinMedica Introduces TNS Recovery Complex, SkinMedica. Retrieved 6 March 2011.
TNS Recovery Complex is the only product containing a professional concentration of NouriCel®, a new cosmetic ingredient from leading tissue-engineering company Advanced Tissue Sciences.
Dermagraft-TC: General Information: Advanced Tissue Sciences, MediLexicon International Ltd. Retrieved 7 May 2011.
Dermagraft-TC is the first human, fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
- (28 March 1997).
Transplant News: Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA, HighBeam Research. Retrieved 7 May 2011.
the Food and Drug Administration has approved Dermagraft-TC
- Circumcision. Daecher M. Icon 1998;2(2):70-3.
- Pitta, Julie: Biosynthetics. pp. 170-171. Forbes.
Note: The 32-page Advanced Tissue Sciences, Inc. 1997 Annual Report refers to "fibroblasts" but does not contain the word "foreskin."
- Hall, C.T. (25 October 1996): Biotech's Big Discovery, in: San Francisco Chronicle:E1, E4.